GlassScriptPhysician profile
Jessica B Wilcox
NPI 1134400732
$7,400.83
in general payments reported to CMS, 2019-2025
48 companies · $1,570 in 2025
The $1,570 reported for 2025 was more than what 93% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,573 · 2022: $1,490 · 2023: $1,387 · 2024: $1,380 · 2025: $1,570.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,338.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,337.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,156.30 | 2021-2025 | |
| Lilly USA, LLC | $737.70 | 2021-2025 | Mounjaro, Zepbound, Emgality |
| Novo Nordisk INC | $685.75 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $659.96 | 2021-2025 | Breztri, Farxiga, Airsupra |
| Amgen INC. | $562.08 | 2021-2025 | Evenity, Otezla, Repatha |
| Glaxosmithkline, LLC. | $415.06 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $382.63 | 2021-2025 | Jardiance, Tradjenta, Glyxambi |
| Pfizer INC. | $286.39 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $266.99 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $216.61 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $131.98 | 2021-2025 | Xifaxan, Trulance |
| Abbott Laboratories | $130.78 | 2022-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Janssen Pharmaceuticals, INC | $129.55 | 2021-2022 | |
| Lifescan, INC. | $121.91 | 2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $109.86 | 2022 |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Wilcox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.